NEJ026: common adverse events reported in the safety population (1/3)1

Image 35@2x.png

Data are n (%). Grade 1-2 events occurring in more than 10% of patients and all grade 3-4 events are shown. No grade 5 events were recorded

Reference

  1. Saito H, et al. Lancet Oncol 2019 20:625–35

NEJ026: common adverse events reported in the safety population (2/3)1

Image 34@2x.png

Data are n (%). Grade 1-2 events occurring in more than 10% of patients and all grade 3-4 events are shown. No grade 5 events were recorded

Reference

  1. Saito H, et al. Lancet Oncol 2019 20:625–35

NEJ026: common adverse events reported in the safety population (3/3)1

Image 33@2x.png

Data are n (%). Grade 1-2 events occurring in more than 10% of patients and all grade 3-4 events are shown. No grade 5 events were recorded

Reference

  1. Saito H, et al. Lancet Oncol 2019 20:625–35